Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Blood|February 7, 2002
Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot studySelina M Luger, Stephen G O'Brien, Janina Ratajczak, et al.
The Journal of Experimental Medicine|September 5, 2002
Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cellsAndrzej Ptasznik, Elzbieta Urbanowska, Suneetha Chinta, et al.
Bone Marrow Transplantation|July 10, 2002
Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive diseaseA D Cohen, S M Luger, C Sickles, et al.
ACS Chemical Biology|June 15, 2011
Phenylpyrrolocytosine as an unobtrusive base modification for monitoring activity and cellular trafficking of siRNAAlexander S Wahba, Fereshteh Azizi, Glen F Deleavey, et al.
Nucleic Acids Research|October 30, 2004
Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing moleculesJ B Opalinska, A Kalota, Lida K Gifford, et al.
Nucleic Acids Research|February 19, 2005
Identification of antisense nucleic acid hybridization sites in mRNA molecules with self-quenching fluorescent reporter moleculesLida K Gifford, Joanna B Opalinska, David Jordan, et al.
Blood|September 25, 2008
Trisomy 21 enhances human fetal erythro-megakaryocytic developmentStella T Chou, Joanna B Opalinska, Yu Yao, et al.
Blood|April 25, 2007
The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young childrenEmmanuelle Clappier, Wendy Cuccuini, Anna Kalota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2009
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemiaAlexander E Perl, Margaret T Kasner, Donald E Tsai, et al.
Nature Genetics|October 3, 1999
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemiaW J Song, M G Sullivan, R D Legare, et al.
Pageof 14